HemOnc Today Current Issue
The following articles appeared in the print edition of HemOnc Today.
Table of Contents
- Early recognition, prevention strategies could reduce costly burden of sepsis in patients with cancer Jennifer R. Southall
-
- Should G-CSF be used to boost the immune system in patients with cancer and sepsis?
- ASH releases guidelines on stem cell transplantation for patients with sickle cell disease Ryan Lawrence
- Cancer experts offer guidance on COVID-19 vaccination for patients with blood cancer Jennifer Byrne
- Choice of terms used to describe cancer may affect patient decisions Ryan Lawrence
- Cost of drugs to control cancer-associated symptoms may add to patient financial toxicity Ryan Lawrence
- Elacestrant extends PFS in advanced breast cancer
- FDA approves Tecartus for B-cell precursor ALL
- Female hem/oncs seek to raise awareness of physician infertility Jennifer Byrne
-
- For patients, economic burden of cancer care exceeds $21 billion Devin McLaughlin
- Hypofractionated radiotherapy an ‘acceptable practice standard’ after prostatectomy Mark Leiser
- Many men with low-risk prostate cancer switch from active surveillance to active treatment Ryan Lawrence
- Neoadjuvant chemotherapy may be optimal first-line treatment in advanced ovarian cancer Ryan Lawrence
- Noncancer causes of death ‘increasingly pertinent’ among men with advanced prostate cancer Ryan Lawrence
- Nut consumption associated with survival benefit among long-term breast cancer survivors Ryan Lawrence
- Oncopeptides withdraws multiple myeloma therapy from U.S. market
- Outgoing ASTRO president reflects on progress, challenges Jennifer Byrne
-
- Colorectal cancer trial misses primary endpoint
- Regimen prolongs PFS in DLBCL
- Practice type influences oncologists’ therapy choice for metastatic renal cell carcinoma Mark Leiser
- Research aims to address clinical challenges of triple-class refractory multiple myeloma Devin McLaughlin
- COVID-19 vaccine responses vary after treatment for lymphoid malignancies Jennifer R. Southall
- Sintilimab extends PFS for patients with pretreated EGFR-mutated NSCLC
- Treatment landscape ‘exciting’ for patients with ALL Jennifer R. Southall
- Vaccination safe for patients with renal cell carcinoma who received checkpoint inhibitors Mark Leiser
-
- ’We are failing Black women’: Experts urge action to reduce disparities in breast cancer Jennifer R. Southall
- AACR names recipient of lectureship on cancer health disparities
- Children’s hospital appoints chief of pediatric hematology-oncology division
- Keck Medical Center of USC names CEO
- Oncologist joins New York Cancer & Blood Specialists
- Thyroid cancer specialist joins Jefferson Health